The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

 

300-million-benicar-settlement-reached

Daiichi Sankyo, the Japanese pharmaceutical manufacturer of Benicar, has agreed to a $300 million settlement for failing to warn consumers that the blood pressure medication could cause gastrointestinal illness.

Did you suffer from and seek treatment for one or more of the following symptoms?

  • Vomiting
  • Chronic diarrhea
  • Rapid and excessive weight loss
  • Dehydration
  • Malnutrition
  • Malabsorption
  • Renal insufficiency or renal failure

Approved by the FDA in 2002, Benicar is a prescription drug used to treat high blood pressure, otherwise known as hypertension, in children and adults.

Hundreds of lawsuits were filed around the country in 2015, many of which were consolidated into a multi-district litigation in New Jersey.  The parties and their lawyers will now turn their attention from litigation to settlement.

The settlement applies to consumers who took the drug prior to May 17, 2015. For those who believe their gastrointestinal illness was caused by a Benicar prescription, action must be taken by August 23, 2017, to qualify for the settlement. Please contact the lawyers at TorHoerman Law at 888-508-6752 or Benicar@thlawyer.com.

Comments are closed.

Of Interest